Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography

Core Insights - Nanox Imaging Ltd announced the presentation of data from five studies supporting its AI Cardiac Solution at the upcoming SCCT meeting in Washington, D.C. [1] - The AI Cardiac Solution utilizes routine chest CT scans to quantify coronary artery calcium (CAC) levels, which are strong predictors of future cardiovascular events [2] Study Presentations - The studies being presented include topics such as the frequency and outcomes of incidentally detected CAC, optimizing preventive cardiology using AI, and enhancing cardiovascular risk assessment through AI [3][4] - Esteemed institutions involved in the presentations include Brigham & Women's Hospital, Einstein Jefferson Medical Center, Corewell Health, Massachusetts General Hospital, and Beilinson Medical Center [7] Company Overview - Nanox focuses on making diagnostic medicine more accessible and affordable globally, aiming to improve early detection and treatment of diseases [5] - The company's ecosystem includes a multi-source Digital Tomosynthesis system, AI-based algorithms for routine CT imaging, a cloud-based infrastructure, and a decentralized marketplace for remote access to radiology and cardiology experts [5] AI Technology Impact - Nanox AI's solutions are designed to target prevalent chronic and acute diseases, helping clinicians extract actionable insights from routine medical imaging [12]